1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ASTRAZENECA PLC - ADR
Astrazeneca plc - ADR XNAS: AZN

Astrazeneca plc - ADR Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and m...

Read More
79.56 -1.54 (-1.90%)
Near 52W High of $82.41
4.5M
XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Astrazeneca plc - ADR is on 23 Sep 2025 for the purpose of Conference, Bank of America Global Healthcare Conference, London [Management] 2025 See details
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
32.0 / 100
Momentum Score
Technically Neutral
58.5 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
87
1Yr Price target upside is 10%
10 analysts

11

S

7

W

1

O

2

T

SWOT Analysis

Astrazeneca plc ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..